Chimerix, Inc.
2505 Meridian Parkway
Durham
North Carolina
27713
United States
Website: http://www.chimerix-inc.com/
326 articles about Chimerix, Inc.
-
Chimerix, Inc. Anti-Infection Drug Fails Phase 2
8/14/2013
-
Chimerix, Inc. Announces Second Quarter 2013 Financial Results
8/14/2013
-
Chimerix, Inc. to Announce Second Quarter Financial Results on August 14, 2013
8/7/2013
-
Chimerix, Inc. Elects Rodman L. Drake to Board of Directors
8/2/2013
-
Chimerix, Inc. to Present at JMP Securities Healthcare Conference
7/2/2013
-
Chimerix, Inc. to Join Russell Indexes on June 28, 2013
6/26/2013
-
Chimerix, Inc. and Biomedical Advanced Research and Development Authority (BARDA) Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox
6/3/2013
-
Chimerix, Inc.'s CMX001 Resistance Data Presented at the 26th International Conference on Antiviral Research
5/16/2013
-
Chimerix, Inc. Announces First Quarter 2013 Financial Results
5/13/2013
-
Data on Chimerix, Inc.'s CMX001 Selected for Two Oral Presentations at the 26th International Conference on Antiviral Research
5/10/2013
-
Chimerix, Inc. to Announce First Quarter Financial Results on May 13, 2013
5/6/2013
-
Chimerix, Inc. Presents at Annual EBMT Meeting: Antiviral Activity of CMX001 in Patients With Life-Threatening Viral Infections
4/29/2013
-
Chimerix, Inc. to Present at the 12th Annual Needham Healthcare Conference
4/26/2013
-
Chimerix, Inc. Announces Final Study Design for Phase 3 SUPPRESS Trial of CMX001 for Prevention of CMV Infection
4/24/2013
-
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs
4/12/2013
-
Chimerix, Inc. Sets Terms for $85 Million IPO
4/2/2013
-
Chimerix, Inc.'s Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantation's Annual Meeting
3/28/2013
-
Chimerix, Inc. Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
3/14/2013
-
FDA Grants Chimerix, Inc. Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
3/12/2013
-
Chimerix, Inc. Files Registration Statement for Proposed Initial Public Offering
3/11/2013